All lines of evidence suggest that PI3K-AKT signaling axis is crucial in GLP-1-induced neuronal differentiation; moreover, it implies that enhancing PI3K-AKT also is a potential treatment for neurodegenerative diseases. The gene discussed is GLP1R; the disease is neurodegenerative disease.